PB1762: ponatinib versus imatinib with reduced-intensity chemotherapy in patients with newly diagnosed philadelphia chromosome–positive (ph+) acute lymphoblastic leukemia (all): ph...

por Jabbour, E., Martinelli, G., Vignetti, M., Kantarjian, Hagop M., Gómez Almaguer, David, Minami, Y., Dombret, H., Hennessy, M., Vorog, A., Wang, B., Ribera, J. M.
Publicado 2022